1-1 of 1
Andrew W. Roberts, M.D., PhD
Close
Sort by
Journal Articles

The BH3 Mimetic, ABT-737, Is Effective Against Bcl-2 Overexpressing Lymphoid Tumors.

Kylie D. Mason, MD, Cassandra J. Vandenberg, PhD, Mark F. van Delft, B.Sc, Andrew H. Wei, M.D., PhD., Suzanne Cory, B.Sc, PhD, Scott L. Clare, M.D., PhD, Andrew W. Roberts, M.D., PhD, David C.S. Huang, M.D., PhD
Journal: Blood
Blood (2006) 108 (11): 826.
https://doi.org/10.1182/blood.V108.11.826.826
Published: 2006